OBJECTIVE: Murine embryonic stem cells can be differentiated into embryoid bodies (EBs), which serve as an in vitro model recapitulating many aspects of embryonic yolk sac hematopoiesis. Differentiation of embryonic stem cells deficient in either Gata-4 or Gata-6 results in EBs with disrupted visceral endoderm (VE). While lack of VE has detrimental effects on hematopoiesis in vivo, it is unclear whether lack of VE affects hematopoiesis in EBs. Therefore, we compared Gata-4 null (G4N) and Gata-6 null (G6N) EBs with wild-type EBs to assess their ability to commit to hematopoietic cells. MATERIALS AND METHODS: EB VE formation was examined using cell-sorting techniques and analysis visceral endoderm gene expression. Hematopoietic progenitor potential of EBs cultured under various conditions was assessed using colony-forming assays. RESULTS: Definitive erythroid, granulocyte-macrophage, and mixed colonies were significantly reduced in G4N and G6N EBs compared to wild-type EBs. Vascular endothelial growth factor (VEGF) expression and secretion were also reduced in both G4N and G6N EBs, consistent with VE serving as a site of VEGF production. Addition of exogenous VEGF(165), to EB cultures completely rescued definitive colony-forming cells in G4N and G6N EBs. This rescue response could be blocked by addition of soluble Flk-1 Fc to EB cultures. Similarly, addition of exogenous Indian hedgehog to EB cultures also recovers the diminishment in definitive hematopoiesis in a reversible manner. CONCLUSION: These results suggest that the absence of VE in G4N and G6N EBs does not prevent emergence of definitive progenitors from EBs. However, the decreased level of VEGF and Indian hedgehog production in VE devoid G4N and G6N EBs attenuates definitive hematopoietic progenitor cell expansion.
OBJECTIVE:Murine embryonic stem cells can be differentiated into embryoid bodies (EBs), which serve as an in vitro model recapitulating many aspects of embryonic yolk sac hematopoiesis. Differentiation of embryonic stem cells deficient in either Gata-4 or Gata-6 results in EBs with disrupted visceral endoderm (VE). While lack of VE has detrimental effects on hematopoiesis in vivo, it is unclear whether lack of VE affects hematopoiesis in EBs. Therefore, we compared Gata-4 null (G4N) and Gata-6 null (G6N) EBs with wild-type EBs to assess their ability to commit to hematopoietic cells. MATERIALS AND METHODS:EB VE formation was examined using cell-sorting techniques and analysis visceral endoderm gene expression. Hematopoietic progenitor potential of EBs cultured under various conditions was assessed using colony-forming assays. RESULTS: Definitive erythroid, granulocyte-macrophage, and mixed colonies were significantly reduced in G4N and G6N EBs compared to wild-type EBs. Vascular endothelial growth factor (VEGF) expression and secretion were also reduced in both G4N and G6N EBs, consistent with VE serving as a site of VEGF production. Addition of exogenous VEGF(165), to EB cultures completely rescued definitive colony-forming cells in G4N and G6N EBs. This rescue response could be blocked by addition of soluble Flk-1 Fc to EB cultures. Similarly, addition of exogenous Indian hedgehog to EB cultures also recovers the diminishment in definitive hematopoiesis in a reversible manner. CONCLUSION: These results suggest that the absence of VE in G4N and G6N EBs does not prevent emergence of definitive progenitors from EBs. However, the decreased level of VEGF and Indian hedgehog production in VE devoid G4N and G6N EBs attenuates definitive hematopoietic progenitor cell expansion.
Authors: Christopher T Lux; Momoko Yoshimoto; Kathleen McGrath; Simon J Conway; James Palis; Mervin C Yoder Journal: Blood Date: 2007-10-11 Impact factor: 22.113
Authors: Jérôme Artus; Panagiotis Douvaras; Anna Piliszek; Joan Isern; Margaret H Baron; Anna-Katerina Hadjantonakis Journal: Dev Biol Date: 2011-10-15 Impact factor: 3.582
Authors: Molly S Stitt-Fischer; Rachel K Ungerman; Daniel S Wilen; Karla Wasserloos; Lara M Renz; Shannon E Raub; Jim Peterson; Linda L Pearce Journal: Radiat Res Date: 2010-09-28 Impact factor: 2.841
Authors: Vladimir Jojic; Tal Shay; Katelyn Sylvia; Or Zuk; Xin Sun; Joonsoo Kang; Aviv Regev; Daphne Koller; Adam J Best; Jamie Knell; Ananda Goldrath; Vladimir Joic; Daphne Koller; Tal Shay; Aviv Regev; Nadia Cohen; Patrick Brennan; Michael Brenner; Francis Kim; Tata Nageswara Rao; Amy Wagers; Tracy Heng; Jeffrey Ericson; Katherine Rothamel; Adriana Ortiz-Lopez; Diane Mathis; Christophe Benoist; Natalie A Bezman; Joseph C Sun; Gundula Min-Oo; Charlie C Kim; Lewis L Lanier; Jennifer Miller; Brian Brown; Miriam Merad; Emmanuel L Gautier; Claudia Jakubzick; Gwendalyn J Randolph; Paul Monach; David A Blair; Michael L Dustin; Susan A Shinton; Richard R Hardy; David Laidlaw; Jim Collins; Roi Gazit; Derrick J Rossi; Nidhi Malhotra; Katelyn Sylvia; Joonsoo Kang; Taras Kreslavsky; Anne Fletcher; Kutlu Elpek; Angelique Bellemarte-Pelletier; Deepali Malhotra; Shannon Turley Journal: Nat Immunol Date: 2013-04-28 Impact factor: 25.606
Authors: Gurjoth S J Deol; Tina N Cuthbert; Mohamed I Gatie; Danielle M Spice; Lindsay R Hilton; Gregory M Kelly Journal: Front Cell Dev Biol Date: 2017-10-25